Lee CH, Jeon SJ, Cho KS, Moon E, Sapkota A, Jun HS, et al
This is the first study to demonstrate that ASK1-p38/JNK regulated LD growth by promoting DGAT2 and GPAT4 targeting to the surface of LDs
MT-1 was engineered to improve the stability and receptor-selectivity profile of -MSH
Treatments are quick, safe, and personalizedperfect for anyone seeking a boost in energy, focus, and balance
The Future of GLP-1 Patches: Current Limitations in 2026 Several pharmaceutical companies have invested in GLP-1 patch technology, but clinical adoption remains limited
Multiple factors made Amino Asylum a priority target: marketing products explicitly for human consumption, selling prescription medications without authorization, using trademarked pharmaceutical terms in advertising, ignoring FDA warning letters, and operating at a scale that made the public health risk significant